📰 Tolerability Data News
Tolerability Data News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tolerability Data. Real-time updates on events, politics, business and more.
May 28, 2024
VANCOUVER, British Columbia, May 28, 2024 -- Xenon Pharmaceuticals Inc. , a neuroscience-focused biopharmaceutical company, announced data presentations highlighting azetukalner clinical data in...
February 14, 2024
Dow Jones Newswires February 14, 2024 01:00 ET ... -February 14, 2024 at 01:00 am EST - MarketScreener
October 26, 2023
—ARIKAYCE® Total Revenue of $79.1 Million for the Third Quarter of 2023 Reflects Highest Quarter of Sales Since Launch and 17% Growth Compared to the Third Quarter of 2022— —Company...
June 26, 2023
/PRNewswire/ -- The "Constrained Peptide Drugs Market - A Global and Regional Analysis: Focus on Peptide Type, Product, and Region-Wise Analysis - Analysis and...
March 16, 2022
Clinically meaningful results with Mazindol ER exhibiting a 39% reduction in ESS from baseline (-4.3 points placebo-adjusted); confirms statistical powering of the ongoing Phase 2a trialSafety and tolerability
March 16, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.
October 5, 2021
Oral presentation to discuss new data updates from the high- and low-dose cohorts from the ongoing Phase 1/2 trial of AXO-AAV-GM1 for the treatment of GM1...